Corey Goodman, venBio. “What would I have done differently?”

Corey Goodman is a prominent scientist and biotech entrepreneur who has made significant contributions to the field of neuroscience. He is currently a managing partner at venBio, a leading life sciences venture capital firm that invests in breakthrough biotech companies.

Goodman began his career as a professor of neurobiology at the University of California, Berkeley, where he conducted groundbreaking research on the development and function of the nervous system. He later served as the president of the biotech company, Renovis, where he led the development of several innovative drugs for the treatment of neurological disorders.

In 2010, Goodman co-founded venBio with Robert Adelman, a fellow biotech entrepreneur. Since then, the firm has invested in a wide range of biotech companies focused on developing new treatments for a variety of diseases, including cancer, autoimmune disorders, and rare genetic diseases.

As a managing partner at venBio, Goodman is responsible for identifying and investing in promising biotech companies, and for providing strategic guidance to the companies in the firm’s portfolio. His 35 years of expertise, co-founding of eight companies, and experience in the field of neuroscience and biotech have helped to make venBio one of the most successful life sciences venture capital firms in the industry.